Mathematical modeling of tumor growth and tumor growth inhibition in oncology drug development
出版年份 2012 全文链接
标题
Mathematical modeling of tumor growth and tumor growth inhibition in oncology drug development
作者
关键词
-
出版物
Expert Opinion on Drug Metabolism & Toxicology
Volume 8, Issue 9, Pages 1057-1069
出版商
Informa Healthcare
发表日期
2012-10-16
DOI
10.1517/17425255.2012.693480
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Pharmacokinetic/Pharmacodynamic Pipeline: Translating Anticancer Drug Pharmacology to the Clinic
- (2011) Qingyu Zhou et al. AAPS Journal
- Comparison of Continuous versus Categorical Tumor Measurement-Based Metrics to Predict Overall Survival in Cancer Treatment Trials
- (2011) M.-W. An et al. CLINICAL CANCER RESEARCH
- Pharmacokinetic-Pharmacodynamic Modeling of Biomarker Response and Tumor Growth Inhibition to an Orally Available Heat Shock Protein 90 Inhibitor in a Human Tumor Xenograft Mouse Model
- (2011) S. Yamazaki et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Optimal Design of Pharmacokinetic Studies
- (2010) Leon Aarons et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Development of a modeling framework to simulate efficacy endpoints for motesanib in patients with thyroid cancer
- (2010) Laurent Claret et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Population pharmacokinetic/pharmacodynamic modeling for the time course of tumor shrinkage by motesanib in thyroid cancer patients
- (2010) Jian-Feng Lu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pharmacokinetic-Pharmacodynamic Modeling of Tumor Growth Inhibition and Biomarker Modulation by the Novel Phosphatidylinositol 3-Kinase Inhibitor GDC-0941
- (2010) L. Salphati et al. DRUG METABOLISM AND DISPOSITION
- Model-Based Drug Development: Strengths, Weaknesses, Opportunities, and Threats for Broad Application of Pharmacometrics in Drug Development
- (2010) Jeffrey D. Wetherington et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Fostering Culture and Optimizing Organizational Structure for Implementing Model-Based Drug Development
- (2010) Liping Zhang et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Modeling the efficacy of trastuzumab-DM1, an antibody drug conjugate, in mice
- (2010) Nelson L. Jumbe et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Comparison of Two Pharmacodynamic Transduction Models for the Analysis of Tumor Therapeutic Responses in Model Systems
- (2009) Jun Yang et al. AAPS Journal
- Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis
- (2009) Brett E. Houk et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- From Trial and Error to Trial Simulation. Part 1: The Importance of Model-Based Drug Development for Antidepressant Drugs
- (2009) G Santen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Elucidation of Relationship Between Tumor Size and Survival in Non-Small-Cell Lung Cancer Patients Can Aid Early Decision Making in Clinical Drug Development
- (2009) Y Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- From Trial and Error to Trial Simulation. Part 2: An Appraisal of Current Beliefs in the Design and Analysis of Clinical Trials for Antidepressant Drugs
- (2009) G Santen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Model-based approaches to increase efficiency of drug development in schizophrenia: a can't miss opportunity
- (2009) Gianluca Nucci et al. Expert Opinion on Drug Discovery
- A Minimal Model of Tumor Growth Inhibition
- (2009) P. Magni et al. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
- Model-Based Prediction of Phase III Overall Survival in Colorectal Cancer on the Basis of Phase II Tumor Dynamics
- (2009) Laurent Claret et al. JOURNAL OF CLINICAL ONCOLOGY
- Re: Antitumor Efficacy Testing in Rodents
- (2009) Italo Poggesi et al. JNCI-Journal of the National Cancer Institute
- Concepts and Challenges in Quantitative Pharmacology and Model-Based Drug Development
- (2008) Liping Zhang et al. AAPS Journal
- Efficacy of Weekly Docetaxel and Bevacizumab in Mesenchymal Chondrosarcoma: A New Theranostic Method Combining Xenografted Biopsies with a Mathematical Model
- (2008) Boris Gorelik et al. CANCER RESEARCH
- A Pharmacodynamic Model for the Time Course of Tumor Shrinkage by Gemcitabine + Carboplatin in Non-Small Cell Lung Cancer Patients
- (2008) L.-S. Tham et al. CLINICAL CANCER RESEARCH
- Pharmacokinetic-Pharmacodynamic Modeling of Biomarker Response and Tumor Growth Inhibition to an Orally Available cMet Kinase Inhibitor in Human Tumor Xenograft Mouse Models
- (2008) S. Yamazaki et al. DRUG METABOLISM AND DISPOSITION
- Antitumor Efficacy Testing in Rodents
- (2008) Melinda G. Hollingshead JNCI-Journal of the National Cancer Institute
- Semi-mechanistic modelling of the tumour growth inhibitory effects of LY2157299, a new type I receptor TGF-β kinase antagonist, in mice
- (2007) Lorea Bueno et al. EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More